MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 89 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,083,736 | -41.5% | 631,520 | -21.1% | 0.06% | -41.7% |
| Q2 2023 | $8,688,000 | -21.2% | 800,000 | -49.9% | 0.10% | -31.3% |
| Q1 2023 | $11,022,136 | +44.1% | 1,597,411 | -16.9% | 0.15% | +45.6% |
| Q4 2022 | $7,647,140 | -33.1% | 1,921,392 | +11.8% | 0.10% | -35.6% |
| Q3 2022 | $11,426,000 | – | 1,718,123 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |